home All News open_in_new Full Article

Kaken agrees to $180M deal to develop Alumis' lead TYK2 inhibitor in Japan

Kaken agrees to $180M deal to develop Alumis' lead TYK2 inhibitor in Japan  Fierce Biotech


today 3 w. ago attach_file Other

attach_file Other
attach_file Other
attach_file Other
attach_file Other
attach_file Other
attach_file Other
attach_file Other
attach_file Other
attach_file Other
attach_file Other
attach_file Other
attach_file Other
attach_file Other
attach_file Other
attach_file Other
attach_file Other
attach_file Other
attach_file Other
attach_file Other
attach_file Other


ID: 3380274473
Add Watch Country

arrow_drop_down